IQVIA Holdings Inc. closed 29.34% below its 52-week high of $256.76, which the company reached on March 14th.
Shares of IQVIA Holdings Inc. IQV rose 1.06% to $185.42 Wednesday, on what proved to be an all-around mixed trading session ...
IQVIA (NYSE:IQV – Get Free Report) was downgraded by equities researchers at StockNews.com from a “buy” rating to a “hold” ...
IQVIA (NYSE:IQV), a leading global provider of AI-powered analytics, technology solutions and clinical research services to the healthcare and life sc ...
At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.
8d
Clinical Trials Arena on MSNIqvia launches Site Lab Navigator platform to streamline clinical trial workflowsThe e-Requisition solution aims to reduce administrative workloads, ensure compliance and improve study performance.
Global contract research organization IQVIA is looking to simplify workflows for its clinical trial investigators with a new ...
With Donald Trump's tit-for-tat tariffs on India looming next month, millions of Americans may have to brace for steeper ...
Victory Capital Management Inc. trimmed its stake in IQVIA Holdings Inc. (NYSE:IQV – Free Report) by 9.2% during the 4th quarter, HoldingsChannel reports. The fund owned 88,756 shares of the medical ...
Citi analyst Patrick Donnelly lowered the firm’s price target on Iqvia (IQV) to $210 from $225 and keeps a Neutral rating on the shares. The ...
IQVIA Laboratories, a leading global drug discovery and development laboratory services organization, announces the launch of ...
IQVIA Holdings (NYSE:IQV) saw a share price increase of 2% over the last week, a period during which it amended its Fifth Amended and Restated Credit Agreement. This amendment, allowing the company to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results